Allow authorized representation in the Drug Courts
Reform ID		F348
Description		Allowing authorized representation in Drug Courts has been proposed to modernize court procedures, reduce the burden of personal attendance, and align the process with global practices that permit legal representatives to appear on behalf of company officials for non-serious cases.
Department		Drug Regulatory Authority of Pakistan - DRAP
Jurisdiction / Location		Federal - Entire Pakistan
Sector		Pharmaceuticals and Healthcare
Start Date		24-06-2025
Target Deadline		30-06-2025
Date Enacted
Implementation Status		In Progress
Progress		30%
CCORR Direction		Simplify
Cost Savings PKR (Mil.)
Evidence